FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Federal Register

Guide on Peptide Clin-Pharm Considerations

Federal Register notice: FDA makes available a draft guidance entitled Clinical Pharmacology Considerations for Peptide Drug Products.

latest-news-card-1

CMC Readiness Pilot Program

Federal Register notice: FDA announces an opportunity to participate in its Chemistry, Manufacturing, and Controls (CMC) Development and Readiness Pil...

Medical Devices

S4 De Novo Authorization for esolution

FDA grants S4 Medical a de novo authorization to market its esolution esophageal deviation device.

latest-news-card-1
Human Drugs

Novartis Recalls Sandimmune Lot

Novartis recalls one lot of its Sandimmune Oral Solution (cyclosporine oral solution, USP), 100 mg/ml due to crystal formation observed in some bottle...

latest-news-card-1
Medical Devices

FDA Updates Alert on Halyard N95 Masks

FDA provides further clarification about a safety alert issued earlier this year that recommended against the use of certain surgical N95 respirators ...

latest-news-card-1
Federal Register

Endogenous Cushings Syndrome Guidance

Federal Register notice: FDA makes available a draft guidance entitled Endogenous Cushings Syndrome: Developing Drugs for Treatment.

latest-news-card-1
Federal Register

Guide on ISO 10993-1 Biological Evaluations

Federal Register notice: FDA posts a final guidance entitled Use of International Standard ISO 109931, Biological Evaluation of Medical Devices Part ...

latest-news-card-1
Federal Register

Combo Product Human Factors Guide

Federal Register notice: FDA makes available a final guidance entitled Application of Human Factors Engineering (HFE) Principles for Combination Produ...

latest-news-card-1
Human Drugs

Senators Reintroduce Opioid Studies Bill

U.S. Senators Joe Manchin (D-WV) and Mike Braun (R-IN) reintroduce their bipartisan FDA Review of Efficacy EERW Double-Blinds (FREED) of Opioids Act.

latest-news-card-1
Human Drugs

House Committee Hearing on Drug Shortages

The House Energy and Commerce Committee announces a 9/14 legislative hearing to discuss legislative proposals on preventing generic drug shortages.